SCHEMBL1695850

SCHEMBL1695850

C=C(C(=O)NC(CC)CO)c1ccc(OCc2cn3ccccc3n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.59
▸ TDP1 Q9NUW8 5/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ PDE10A Q9Y233 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ HPGD P15428 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ TSHR P16473 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ HCRTR1 O43613 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488101 0.76 KDM4E (1.00) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL1695853 0.75 KDM4E (0.60) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL23488102 0.75 KDM4E (0.80) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL17694678 0.70 KDM4E (0.78) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL1695910 0.69 KDM4E (0.58) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL1695828 0.69 KDM4E (0.58) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL4726835 0.68 NPC1 (0.75) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL11427962 0.67 KDM4E (0.72) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A
SCHEMBL244257 0.67 KDM4E (0.56) KDM4ETDP1ALDH1A1NPC1RAB9A
SCHEMBL21392826 0.66 KDM4E (0.56) KDM4ETDP1SMN1; SMN2ALDH1A1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138657-A1 ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-11-10 — — WO disclosed
Send feedback